Sha Pharmaceuticals Inc is categorized under Wholesale Pharmaceutical Products in Pelham, AL and active since 2006.
Sha Pharmaceuticals Inc was established in 2006, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Wholesale Pharmaceutical Products business, which does work in the B2B market, and is classified as a Wholesale Pharmaceutical Products, under code number 424210 by the NAICS.
If you are seeking more information, feel free to contact Marlene Caceres Marrero at the company’s single location by writing to 250 Cahaba Valley Parkway, Pelham, Alabama AL 35124 or by phoning (205) 982-7141. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Sha Pharmaceuticals Inc |
Contact Person: | Marlene Caceres Marrero |
Address: | 250 Cahaba Valley Parkway, Pelham, Alabama 35124 |
Phone Number: | (205) 982-7141 |
Annual Revenue (USD): | $500.000 to $999.999 |
Founded: | 2006 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Wholesale Pharmaceutical Products |
SIC Code: | 5122 |
NAICS Code: | 424210 |
Share This Business: |
Sha Pharmaceuticals Inc was started in 2006 to provide professional Wholesale Pharmaceutical Products under the SIC code 5122 and NAICS code 424210. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Marlene Caceres Marrero for inquiries that concern Sha Pharmaceuticals Inc by calling the company number (205) 982-7141, as your correspondence is most welcome. Additionally, the physical location of the single location of Sha Pharmaceuticals Inc can be found at the coordinates 33.34228,-86.787843 as well as the street address 250 Cahaba Valley Parkway in Pelham, Alabama 35124.
For its online presence, you may visit Sha Pharmaceuticals Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.